stockrowAdaptive Biotechnologies Corporation
ADPT Healthcare Diagnostics & Research
Adaptive Biotechnologies Corporation’s revenue for fiscal 2025 (year ended December 2025) was $277.0 million, up 54.8% from fiscal 2024.
- Revenue
- −10.7%
- EPS
- −66.7%
- Free cash flow
- +201.9%
Quarter to September 2026, against a year earlier
Follow ADPT
Alert me
Adaptive Biotechnologies Corporation (ADPT) Revenue growth
Adaptive Biotechnologies Corporation's revenue growth over the twelve months to 30 September 2026 was 17.9%, down 36.9 percentage points from fiscal 2025 (54.8%). Over the past ten years it has ranged from −30.9% (fiscal 2017) to 56.9% (fiscal 2021); the current reading is higher than 89% of that period. That is above the Diagnostics & Research industry median of 8.99% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 54.8% | 49.67 |
| FY2024 | 5.10% | 13.21 |
| FY2023 | −8.11% | (28.17) |
| FY2022 | 20.1% | (36.82) |
| FY2021 | 56.9% | 41.23 |
| FY2020 | 15.7% | (37.18) |
| FY2019 | 52.8% | 8.06 |
| FY2018 | 44.8% | 75.70 |
| FY2017 | −30.9% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −10.7% | (32.25) |
| Jun 2026 | 21.5% | (13.61) |
| Mar 2026 | 35.1% | (15.90) |
| Dec 2025 | 51.0% | (51.34) |
| 29 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BLLN BillionToOne, Inc. compare | 76.5% |
| CDNA CareDx, Inc. compare | 38.9% |
| WGS GeneDx Holdings Corp. compare | 25.4% |
| RDNT RadNet, Inc. compare | 18.9% |
| ADPT Adaptive Biotechnologies Corporation | 17.9% |
| VCYT Veracyte, Inc. compare | 17.5% |
| GRAL GRAIL, Inc. compare | 17.5% |
| NEO NeoGenomics, Inc. compare | 11.1% |
| SHC Sotera Health Company compare | 6.90% |
| Diagnostics & Research industry median | 8.99% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ADPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement